Spravato® Esketamine Treatment
Spravato® (Esketamine) Treatment at Psychvisit At Psychvisit, we are proud to offer Spravato® (Esketamine) treatment, an innovative and FDA-approved therapy for adults suffering from treatment-resistant depression or major depressive disorder (MDD) with suicidal thoughts. This groundbreaking medication offers new hope for those who have not found relief with traditional treatments. What Is Spravato®? Spravato® is a prescription nasal spray containing esketamine, a fast-acting medication derived from ketamine. When combined with an oral antidepressant, it has been shown to provide significant improvement in depressive symptoms. Why Choose Spravato®? - Rapid Relief: Experience a faster onset of symptom improvement compared to traditional medications. - Proven Effectiveness: Clinically demonstrated to reduce symptoms of depression, even in hard-to-treat cases. - Innovative Approach: Targets different pathways in the brain to promote healing and mood regulation. How It Works: 1. Initial Evaluation: Our team will assess your medical history and discuss whether Spravato® is the right option for you. 2. Supervised Treatment: Spravato® is administered in our clinic under direct supervision to ensure safety and comfort. 3. Ongoing Care: Regular sessions are paired with supportive therapies and follow-ups to track your progress. Who Can Benefit from Spravato®? Spravato® is recommended for adults who: - Have not responded to multiple antidepressant treatments. - Experience persistent depressive symptoms or suicidal ideation. - Seek a cutting-edge, research-backed treatment option. Your Path to Hope and Healing At Psychvisit, we are dedicated to providing compassionate, evidence-based care to help you overcome depression and reclaim your life. Request Your Spravato® Treatment today and take the first step toward lasting wellness.
Sign Up
Concierge Psychiatry Subscription
Monthly Subscription Fee
USD $150
Suboxone Treatment Subscription
Monthly Subscription Fee
USD $200
Genesight Testing